Drug
Exubera clinical trials
- studies test it
- 10
- open now
- 0
- in phase 3
- 4
- first study started
- 1999
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2006 (5)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 3
- 4
- Phase 4
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 1
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Exubera is read from its arms, and is right about nine times in ten.
Testing it · 10
- A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®CompletedPhase 4PfizerNCT00391027Written as Inhaled Human Insulin (Exubera®)
- Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes MellitusTerminatedPhase 2PfizerNCT00143247Written as Exubera® (inhaled insulin)
- Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 DiabetesCompletedPhase 3PfizerNCT00348374Written as Exubera
- Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 DiabetesTerminatedPhase 3PfizerNCT00527397Written as CP-464,005
- A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®TerminatedPhase 4PfizerNCT00356421Written as Inhaled Human Insulin (Exubera®)
- A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.TerminatedPhase 4PfizerNCT00437489Written as Inhaled Human Insulin (Exubera)
- Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 DiabetesCompletedPhase 4University of PittsburghNCT00315952Written as Exubera
- US Inhaled Insulin Dose Titration StudyCompletedPhase 3PfizerNCT00246623Written as Exubera (inhaled insulin)
- A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and LantusCompletedPhase 4PfizerNCT00367445Written as Inhaled Human Insulin (Exubera)
- Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 DiabetesCompletedPhase 3PfizerNCT00424411Written as Inhaled human insulin (EXUBERA™)